104 related articles for article (PubMed ID: 26774343)
1. Kazinol-E is a specific inhibitor of ERK that suppresses the enrichment of a breast cancer stem-like cell population.
Jung YC; Han S; Hua L; Ahn YH; Cho H; Lee CJ; Lee H; Cho YY; Ryu JH; Jeon R; Kim WY
Biochem Biophys Res Commun; 2016 Feb; 470(2):294-299. PubMed ID: 26774343
[TBL] [Abstract][Full Text] [Related]
2. Computational design, chemical synthesis, and biological evaluation of a novel ERK inhibitor (BL-EI001) with apoptosis-inducing mechanisms in breast cancer.
Liu B; Fu L; Zhang C; Zhang L; Zhang Y; Ouyang L; He G; Huang J
Oncotarget; 2015 Mar; 6(9):6762-75. PubMed ID: 25742792
[TBL] [Abstract][Full Text] [Related]
3. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
Ahmadipour F; Noordin MI; Mohan S; Arya A; Paydar M; Looi CY; Keong YS; Siyamak EN; Fani S; Firoozi M; Yong CL; Sukari MA; Kamalidehghan B
Drug Des Devel Ther; 2015; 9():1193-208. PubMed ID: 25759564
[TBL] [Abstract][Full Text] [Related]
4. Evodiamine selectively targets cancer stem-like cells through the p53-p21-Rb pathway.
Han S; Woo JK; Jung Y; Jeong D; Kang M; Yoo YJ; Lee H; Oh SH; Ryu JH; Kim WY
Biochem Biophys Res Commun; 2016 Jan; 469(4):1153-8. PubMed ID: 26713361
[TBL] [Abstract][Full Text] [Related]
5. Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population.
Ciccarelli C; Vulcano F; Milazzo L; Gravina GL; Marampon F; Macioce G; Giampaolo A; Tombolini V; Di Paolo V; Hassan HJ; Zani BM
Mol Cancer; 2016 Feb; 15():16. PubMed ID: 26897742
[TBL] [Abstract][Full Text] [Related]
6. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
7. Antitumor and anticancer stem cell activity of a poly ADP-ribose polymerase inhibitor olaparib in breast cancer cells.
Shimo T; Kurebayashi J; Kanomata N; Yamashita T; Kozuka Y; Moriya T; Sonoo H
Breast Cancer; 2014 Jan; 21(1):75-85. PubMed ID: 22454224
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.
Sunayama J; Matsuda K; Sato A; Tachibana K; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
Stem Cells; 2010 Nov; 28(11):1930-9. PubMed ID: 20857497
[TBL] [Abstract][Full Text] [Related]
9. Kazinol B from Broussonetia kazinoki improves insulin sensitivity via Akt and AMPK activation in 3T3-L1 adipocytes.
Lee H; Li H; Jeong JH; Noh M; Ryu JH
Fitoterapia; 2016 Jul; 112():90-6. PubMed ID: 27223849
[TBL] [Abstract][Full Text] [Related]
10. An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells.
Guo Y; Zhang X; Meng J; Wang ZY
Eur J Pharmacol; 2011 May; 658(2-3):114-22. PubMed ID: 21376032
[TBL] [Abstract][Full Text] [Related]
11. PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P.
Huang B; Fu SJ; Fan WZ; Wang ZH; Chen ZB; Guo SJ; Chen JX; Qiu SP
Cancer Lett; 2016 Jun; 376(1):148-54. PubMed ID: 27037060
[TBL] [Abstract][Full Text] [Related]
12. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
13. Kazinol C from Broussonetia kazinoki activates AMP-activated protein kinase to induce antitumorigenic effects in HT-29 colon cancer cells.
Kim HS; Lim J; Lee DY; Ryu JH; Lim JS
Oncol Rep; 2015 Jan; 33(1):223-9. PubMed ID: 25394483
[TBL] [Abstract][Full Text] [Related]
14. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
15. Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways.
Chauvin L; Goupille C; Blanc C; Pinault M; Domingo I; Guimaraes C; Bougnoux P; Chevalier S; Mahéo K
Biochim Biophys Acta; 2016 Apr; 1861(4):380-90. PubMed ID: 26821209
[TBL] [Abstract][Full Text] [Related]
16. Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells.
Nami B; Donmez H; Kocak N
Exp Toxicol Pathol; 2016 Aug; 68(7):419-26. PubMed ID: 27350212
[TBL] [Abstract][Full Text] [Related]
17. Leptin promotes the proliferation and migration of human breast cancer through the extracellular-signal regulated kinase pathway.
Yuan HJ; Sun KW; Yu K
Mol Med Rep; 2014 Jan; 9(1):350-4. PubMed ID: 24213635
[TBL] [Abstract][Full Text] [Related]
18. An autocrine/paracrine circuit of growth differentiation factor (GDF) 15 has a role for maintenance of breast cancer stem-like cells.
Sasahara A; Tominaga K; Nishimura T; Yano M; Kiyokawa E; Noguchi M; Noguchi M; Kanauchi H; Ogawa T; Minato H; Tada K; Seto Y; Tojo A; Gotoh N
Oncotarget; 2017 Apr; 8(15):24869-24881. PubMed ID: 28206960
[TBL] [Abstract][Full Text] [Related]
19. The proliferative role of insulin and the mechanism underlying this action in human breast cancer cell line MCF-7.
Chen H; Zhang ZW; Guo Y; Wang Y; Liu Y; Luo N; Zhu Y
J BUON; 2012; 17(4):658-62. PubMed ID: 23335521
[TBL] [Abstract][Full Text] [Related]
20. Ell3 stimulates proliferation, drug resistance, and cancer stem cell properties of breast cancer cells via a MEK/ERK-dependent signaling pathway.
Ahn HJ; Kim G; Park KS
Biochem Biophys Res Commun; 2013 Aug; 437(4):557-64. PubMed ID: 23850691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
